Managed Account Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CS
Managed Account Advisors's XBI Position: Q2 2015 in Review
Managed Account Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 400% in Q2 2015, buying an estimated $622K and bringing the position to 9,999 shares worth $841K. The position accounts for ﹤0.01% of the portfolio, ranked #2165.
Managed Account Advisors first reported a position in XBI in Q1 2015 and has held it in 2 quarters since. 193 funds tracked by Wall St. Rank hold XBI as of Q2 2015.
- Managed Account Advisors held 9,999 shares of State Street SPDR S&P Biotech ETF worth $841K as of Q2 2015.
- Managed Account Advisors bought 8,001 State Street SPDR S&P Biotech ETF shares in Q2 2015, an estimated $622K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2165 holding.
- Managed Account Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and has held it in 2 quarters since.
- 193 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2015.
Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.